Thomas Gurry

Co-founder & CEO @myotahealth | translational #microbiome researcher specialised in fibre fermentation

[Thomas Gurry @ThomasGurry]

Very pleased to share the preprint to our work with Tu Nguyen, @seaweedomics and @ejalm on differences in fermentation capabilities (specifically, the ability to produce Short Chain Fatty Acids from different dietary fibers) between healthy individuals:

https://t.co/G7YqA59VOB

[myota @myotahealth]

'Fibre reduces the risk of heart disease and bowel cancer, improves the immune system and reduces inflammation, yet few of us eat enough of it.'

Thank you for the feature @SheerLuxe !

Continue reading: https://t.co/TB1eApqvyX

#fibre #guthealth

[Thomas Gurry @ThomasGurry]

Nice study looking in more detail at the functional characteristics of longevity-promoting gut microbiota in centenarians. It provides some non-bioinformatic evidence for antioxidant properties of the microbiome being one important factor.

https://t.co/jgB3T2gfqD

[Thomas Gurry @ThomasGurry]

@travishughes Ugh that is super frustrating Travis, blows my mind how someone of your talent can face this kind of thing. It's very brave of you to post this. Serves as a reminder that we all have to fight hard at times, and that nothing in life is for free, even for the best of the best!

[Thomas Gurry @ThomasGurry]

@CCorzett @USCDornsife @CellCellPress @globalmicrobiom Beautiful photo @CCorzett - congratulations!!

[Mathieu Groussin @mgroussi]

Our new paper with @mathildpoyet just came out! It’s about the gut microbiome, industrialization and horizontal gene transfers - check it out:
https://t.co/lN4yYIgkIx Fresh from the @ejalm lab.

[Mathilde Poyet @mathildpoyet]

Excited to share our article presenting the @globalmicrobiom initiative and releasing our first batch of data and results! This work highlights how microbiomes acquire new functionality based on host lifestyle. @CellCellPress.
.
https://t.co/0I5QwB4Br3

[Finch Therapeutics @finch_tx]

Our IPO is an exciting step that will help fuel our mission to transform lives with #microbiome therapeutics. We thank our incredible team members, board members, investors, business partners, and the clinicians and patients that have participated in our clinical trials.

[Eric Topol @EricTopol]

Just out @TheLancet: Largest study of reinfection, whole country of Denmark
—0.65% after prior covid
—Protection ~80%, lasts ≥ 7 months
—Age ≥ 65 protection reduced to 47%
https://t.co/xMn3tKaja0
@SteenEtTo @uni_copenhagen @SSI_dk

[Thomas Gurry @ThomasGurry]

Oatmeal for the win https://t.co/fGcPj6gMDG

[Eric Alm @ejalm]

if i had the chance to do another postdoc in comp bio, this is the position i would apply for

[Thomas Gurry @ThomasGurry]

Wow. I suppose it was only a matter of time, but when I started studying protein folding as a graduate student, this kind of predictive accuracy (independent of the method used) seemed very far away. Pretty impressive. https://t.co/eWrtb96Hjz

[Claire Duvallet @cduvallet]

@BiobotAnalytics is growing our data team and we're hiring! Join us as Head of Data to:

🌳 structure & grow our data team
🤓 nurture a company-wide data-driven culture
📊 solidify Biobot as a leader in public health data science

Check it out! https://t.co/fwKTniW1rX

[Thomas Gurry @ThomasGurry]

Really nice work from Vinod Gupta, @jsung0906 et al. at the Mayo Clinic introducing the Gut Microbiome Health Index (GMHI), calculated from stool metagenomic sequencing data, as a predictor of disease independent of clinical indication:

https://t.co/1XC58S9uZS

[Dr. Rhonda Patrick @foundmyfitness]

A meta-analysis of 40 clinical trials found that supplementation with fish oil is associated with a 35% reduced risk of fatal heart attacks, a 13% reduced risk of heart attacks, and a 9% reduced risk of fatal coronary heart disease.
https://t.co/DnQRPMw4CL

[Zain Kassam MD, MPH @DrZainSays]

Wonderful work @DrJessicaA @ckellymd @grinsa01 @bhmullish - a monumental lift, and highlights the safety of microbiome therapeutics in IBD patients with concomitant CDI

[Thomas Gurry @ThomasGurry]

Beautiful news and views article by ⁦@gibbological⁩ on successional dynamics of keystone species in the gut microbiome https://t.co/xMwqEEva9u

[Thomas Gurry @ThomasGurry]

Very nice work by Holmes et al. in Lawrence David’s group. More evidence and one step closer to precision prebiotics for disease prevention. https://t.co/iJP99HsLId

[Scott Anderson @Psychobiotic]

Ingestion of Lactobacillus intestinalis and Lactobacillus reuteri causes depression- and anhedonia-like phenotypes in antibiotic-treated mice via the vagus nerve.
More evidence that the blues can be transferred, via the vagus.
https://t.co/lPevUjnW2t

[Dr. Kathy McCoy @KathyDMcCoy]

(1/2) Very excited to share our latest paper out at @ScienceMagazine on microbiota-derived inosine and its role in cancer immune checkpoint blockade therapy. https://t.co/K3mT1TBiUM